• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射消旋普萘洛尔在临界高血压和持续性高血压中的药代动力学比较。

Comparison of the pharmacokinetics of intravenous dl-propranolol in borderline and permanent hypertension.

作者信息

Weiss Y A, Safar M E, Chevillard C, Frydman A, Simon A, Lemaire P, Alexandre J M

出版信息

Eur J Clin Pharmacol. 1976;10(6):387-93. doi: 10.1007/BF00563074.

DOI:10.1007/BF00563074
PMID:1001353
Abstract

In borderline and permanent hypertensives after rapid i.v. injection of dl-propranolol 0.2 mg/kg plasma levels were measured and were fitted to a two-compartment open-model. In borderline patients, characterized by a high basal cardiac output (CO), plasma levels were always lower than in permanent hypertensives. The biological half-life was reduced and the central volume of distribution, volume of distribution at pseudo-equilibrium and total clearance (TC) were markedly increased. In the overall population, there was a significant positive correlation between CO and TC. Rapid achievement of a predetermined plateau in each group constituted experimental proof of the validity of the two-compartment open-model for kinetic analysis of propranolol i.v. If kinetic parameters from permanent hypertensive were applied to borderline hypertensives a lower plateau was obtained. Thus, in so far as beta-blockade is related to plasma level of propranolol, an increased intravenous dose may be required in patients with high CO.

摘要

在临界高血压和持续性高血压患者中,快速静脉注射0.2mg/kg的dl-普萘洛尔后,测定血浆水平,并将其拟合为二室开放模型。在以高基础心输出量(CO)为特征的临界高血压患者中,血浆水平始终低于持续性高血压患者。生物半衰期缩短,中央分布容积、准平衡时分布容积和总清除率(TC)显著增加。在总体人群中,CO与TC之间存在显著正相关。每组快速达到预定平台期构成了二室开放模型用于静脉注射普萘洛尔动力学分析有效性的实验证据。如果将持续性高血压患者的动力学参数应用于临界高血压患者,则会得到较低的平台期。因此,就β受体阻滞与普萘洛尔血浆水平相关而言,高CO患者可能需要增加静脉剂量。

相似文献

1
Comparison of the pharmacokinetics of intravenous dl-propranolol in borderline and permanent hypertension.静脉注射消旋普萘洛尔在临界高血压和持续性高血压中的药代动力学比较。
Eur J Clin Pharmacol. 1976;10(6):387-93. doi: 10.1007/BF00563074.
2
Studies of the absorption and removal of propranolol in hypertensive patients during therapy.高血压患者治疗期间普萘洛尔吸收与清除情况的研究。
Circulation. 1975 Aug;52(2):313-8. doi: 10.1161/01.cir.52.2.313.
3
No stereoselective first-pass hepatic extraction of propranolol.普萘洛尔不存在肝脏首过效应的立体选择性提取。
Clin Pharmacol Ther. 1981 Sep;30(3):291-6. doi: 10.1038/clpt.1981.162.
4
[Pharmacokinetics of propranolol, phenytoin and lidocaine in hypercholesterolemic rabbits].
J Pharmacol. 1983 Jan-Mar;14(1):47-55.
5
Effect of oral activated charcoal on propranolol pharmacokinetics following intravenous administration to rabbits.口服活性炭对兔静脉注射普萘洛尔后药代动力学的影响。
J Clin Pharm Ther. 1993 Feb;18(1):39-44. doi: 10.1111/j.1365-2710.1993.tb00564.x.
6
Intravenous propranolol administration: a method for rapidly achieving and sustaining desired plasma levels.静脉注射普萘洛尔:一种快速达到并维持所需血浆水平的方法。
Clin Pharmacol Ther. 1976 Nov;20(5):517-23. doi: 10.1002/cpt1976205517.
7
Kinetics and cardiac effects of propranolol in humans.普萘洛尔在人体中的动力学及心脏效应
Klin Wochenschr. 1982 May 17;60(10):521-5. doi: 10.1007/BF01756098.
8
Isoproterenol sensitivity and total body clearance of propranolol in hypertensive patients.高血压患者中普萘洛尔的异丙肾上腺素敏感性及全身清除率
J Clin Pharmacol. 1976 Apr;16(4):174-83. doi: 10.1002/j.1552-4604.1976.tb01514.x.
9
Antihypertensive effect of propranolol in conscious spontaneously hypertensive rats: central hemodynamics, plasma volume, and renal function during beta-blockade with propranolol.普萘洛尔对清醒自发性高血压大鼠的降压作用:普萘洛尔β受体阻滞期间的中心血流动力学、血浆容量及肾功能
J Cardiovasc Pharmacol. 1982 Nov-Dec;4(6):903-14. doi: 10.1097/00005344-198211000-00005.
10
Relationship of propranolol pharmacokinetics to antihypertensive effect and beta-adrenergic blockade in the treatment of hypertension.普萘洛尔药代动力学与高血压治疗中降压效果及β-肾上腺素能阻滞的关系。
Eur J Clin Pharmacol. 1980 Nov;18(5):391-4. doi: 10.1007/BF00636790.

引用本文的文献

1
Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.体外治疗β-肾上腺素能拮抗剂中毒:EXTRIP 工作组的系统评价和建议。
Crit Care. 2021 Jun 10;25(1):201. doi: 10.1186/s13054-021-03585-7.
2
Clinical pharmacokinetics of buffered propranolol sublingual tablet (Promptol™)-application of a new "physiologically based" model to assess absorption and disposition.缓冲型普萘洛尔舌下片剂(Promptol™)的临床药代动力学-应用新型“生理基础”模型评估吸收和处置。
AAPS J. 2013 Jul;15(3):787-96. doi: 10.1208/s12248-013-9479-1. Epub 2013 Apr 19.
3
Pharmacokinetics of propranolol.

本文引用的文献

1
VARYING HEMODYNAMIC PATTERNS IN ESSENTIAL HYPERTENSION.原发性高血压的不同血流动力学模式
Am J Med Sci. 1965 Jul;250:24-35. doi: 10.1097/00000441-196507000-00005.
2
The hemodynamics in labile hypertension.
Am Heart J. 1962 Feb;63:188-95. doi: 10.1016/0002-8703(62)90195-3.
3
Treatment of hypertension with propranolol.用普萘洛尔治疗高血压。
Br Med J. 1969 Jan 4;1(5635):7-16. doi: 10.1136/bmj.1.5635.7.
普萘洛尔的药代动力学
J Pharmacokinet Biopharm. 1981 Aug;9(4):419-29. doi: 10.1007/BF01060886.
4
A standard approach to compiling clinical pharmacokinetic data.一种汇编临床药代动力学数据的标准方法。
J Pharmacokinet Biopharm. 1981 Feb;9(1):59-127. doi: 10.1007/BF01059343.
5
Modelling of initial distribution of drugs following intravenous bolus injection.
Eur J Clin Pharmacol. 1983;24(1):121-6. doi: 10.1007/BF00613938.
6
(+)-Propranolol clearance, an estimation of hepatic blood flow in man.(+)-普萘洛尔清除率,人体肝血流量的一种估计指标。
Br J Clin Pharmacol. 1978 May;5(5):457-60. doi: 10.1111/j.1365-2125.1978.tb01655.x.
4
Hemodynamic studies in patients with borderline blood pressure elevation.临界血压升高患者的血流动力学研究。
Circulation. 1968 Aug;38(2):282-8. doi: 10.1161/01.cir.38.2.282.
5
Interrelationships of hepatic blood flow, cardiac output, and blood levels of lidocaine in man.人体肝脏血流量、心输出量与利多卡因血药浓度之间的相互关系。
Circulation. 1971 Feb;43(2):205-11. doi: 10.1161/01.cir.43.2.205.
6
Plasma propranolol levels in adults with observations in four children.成人血浆普萘洛尔水平及对四名儿童的观察结果
Clin Pharmacol Ther. 1970 Jan-Feb;11(1):112-20. doi: 10.1002/cpt1970111112.
7
Physiological and clinical aspects of beta adrenergic blockade.β肾上腺素能阻滞剂的生理和临床方面
Ann N Y Acad Sci. 1967 Feb 10;139(3):1003-9. doi: 10.1111/j.1749-6632.1967.tb41268.x.
8
The almost complete hepatic extraction of propranolol during intravenous administration in the dog.在狗静脉注射期间普萘洛尔几乎被肝脏完全摄取。
Life Sci I. 1971 Dec 15;10(24):1417-21. doi: 10.1016/0024-3205(71)90271-2.
9
Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension.
Circulation. 1971 Sep;44(3):413-8. doi: 10.1161/01.cir.44.3.413.
10
The disposition of propranolol. I. Elimination during oral absorption in man.普萘洛尔的处置。I. 人体口服吸收过程中的消除
Pharmacology. 1972;7(3):159-68. doi: 10.1159/000136285.